Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
0.7502
-0.0258 (-3.32%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Sol-Gel Technologies Employees
Sol-Gel Technologies had 36 employees as of December 31, 2023. The number of employees decreased by 19 or -34.55% compared to the previous year.
Employees
36
Change (1Y)
-19
Growth (1Y)
-34.55%
Revenue / Employee
$325,194
Profits / Employee
-$265,833
Market Cap
20.90M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SLGL News
- 9 days ago - Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S. - GlobeNewsWire
- 18 days ago - Global Sol-Gel Coatings Market Research 2025-2035: Competitive Landscape, Functional Properties and Applications, End-users, Technology Fundamentals, Overview and Growth Analysis - GlobeNewsWire
- 5 months ago - Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 8 months ago - UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 9 months ago - Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 10 months ago - Sol-Gel Technologies Announces Management Realignment - GlobeNewsWire
- 1 year ago - Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 1 year ago - Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel - GlobeNewsWire